Paediatric Cancer Treatment in Hyderabad — Expert Childhood Cancer Care Across 7 Locations

Paediatric Cancer in Hyderabad — What Every Parent Needs to Know

A childhood cancer diagnosis is one of the most devastating things a family can face. In those first days after the news, parents need two things above everything else: honest information about what is ahead, and a team they can trust to put their child first at every step. The good news — and it is real, not just comforting words — is that childhood cancer as a whole is far more curable than most adult cancers.

With modern treatment protocols, over 80% of children diagnosed with cancer in specialist oncology settings survive long-term. At CION Cancer Clinics, our haematology, medical oncology, and surgical oncology team treats children and adolescents with cancer across 7 Hyderabad locations — bringing evidence-based childhood cancer care closer to families, backed by NABH accreditation and NCCN protocol-driven treatment planning.

Why Childhood Cancer Is Different from Adult Cancer — and Why That Matters

When a parent hears their child has cancer, they often imagine adult cancer — the difficult, slow battles they've seen in relatives. Childhood cancer is genuinely different, and understanding why gives families a more accurate picture of what treatment involves.

Most Common Childhood Cancers We Treat

The childhood cancers we manage most often, with current 5-year survival figures from specialist oncology centres.

Note: Survival figures are for children treated at specialist oncology centres following current international protocols. Individual outcomes depend on cancer type, risk group, age at diagnosis, and response to initial treatment.

Warning Signs of Cancer in Children

Childhood cancer symptoms are often vague and overlap with common childhood illnesses — which is why diagnosis is sometimes delayed. Symptoms that are persistent, worsening, or unexplained should be assessed by a paediatrician and, if needed, an oncologist.

• Persistent tiredness, paleness, or weakness — paleness of the skin or lips may indicate anaemia from leukaemia
• Unexplained fever lasting more than 2 weeks — recurrent or prolonged fevers without a clear infectious cause
• Easy bruising or unexpected bleeding — bruising from minimal contact, frequent nosebleeds, or gum bleeding without dental cause
• Frequent infections — a child who gets one infection after another may have a weakened immune system from leukaemia or lymphoma
• Swollen lymph nodes — lumps in the neck, armpit, or groin lasting more than 2 to 4 weeks without a clear infection
• Bone or joint pain not linked to injury — particularly pain present at night, that wakes the child, or in an unusual location
• A lump or swelling anywhere in the body — a painless lump in the abdomen, neck, or elsewhere that appears and grows
• Morning headaches with vomiting — particularly those that worsen with lying down; may suggest a brain tumour causing raised pressure
• Changes in vision, walking, coordination, or behaviour — sudden change in how a child moves, speaks, or acts
• Unexplained weight loss — significant weight loss without a change in diet or activity

Any symptom from this list that persists for more than 2 to 4 weeks, or that is worsening, should be evaluated by a specialist. Speak to a CION paediatric oncologist — early diagnosis gives children the best chance of successful treatment.

What Causes Childhood Cancer?

In the majority of children, there is no identifiable external cause. This can be deeply frustrating for parents who search for an explanation. The most important message is this: childhood cancer is not caused by anything a parent did or did not do, and it is not caused by the child's diet, activity, screen time, or environment in the vast majority of cases.

Known factors that can increase risk include:

• Certain inherited genetic conditions — Down syndrome, Li-Fraumeni syndrome, neurofibromatosis, and a handful of other rare inherited conditions carry a meaningfully higher risk of specific childhood cancers
• Previous radiation treatment — high-dose radiation to the body during treatment for another condition can, in rare cases, increase the risk of a subsequent cancer
• Inherited cancer syndromes — some gene faults that run in families increase the risk of certain childhood cancers; genetic testing and counselling can identify these
• For most children, no cause is found — and none needs to be. The focus should be on treatment, not on finding something or someone to blame

Why Families Choose CION for Childhood Cancer Treatment in Hyderabad

Twelve reasons families pick CION — across volume, paediatric oncology expertise, current protocols, and supportive care.

How Is Childhood Cancer Diagnosed?

CION's diagnostic pathway integrates blood markers, imaging, bone marrow examination, and biopsy where required to confirm the cancer type and risk group before any treatment decision is made.

Blood Tests

A full blood count is usually the first investigation for a child with persistent fatigue, pallor, or frequent infections. Abnormalities in the blood — low red cells, very high or very low white cells, low platelets — can indicate leukaemia or lymphoma. Elevated markers in the blood may suggest other solid tumour types.

Imaging

• Ultrasound — a painless, radiation-free scan; the first imaging for abdominal lumps (to check for Wilms tumour or neuroblastoma), swollen lymph nodes, and other lumps
• MRI — the most detailed imaging for brain tumours, spinal cord tumours, and soft tissue masses; no radiation; ideal for children
• CT Scan — for staging and checking spread; used when speed and detail about the chest, abdomen, or pelvis is needed; involves radiation so used selectively in children
• Bone scan or PET-CT — to check for spread of certain solid tumours to bones or other organs

Bone Marrow Examination

For suspected leukaemia or lymphoma, a small sample of bone marrow is taken — usually from the back of the hip — under sedation or anaesthesia. The sample is examined under a microscope to confirm the type of leukaemia or lymphoma and determine the risk group, which directly determines the treatment intensity.

Biopsy

For solid tumours — a lymph node, a mass in the abdomen, or a bone lesion — a small tissue sample is taken and examined under a microscope to confirm the cancer type. For most solid tumours, chemotherapy begins before surgery to shrink the tumour; the biopsy is often performed at the start of chemotherapy rather than requiring open surgery first.

Risk Groups — How Childhood Cancer Treatment Is Personalised

Parents of children newly diagnosed with cancer are sometimes confused when doctors talk about risk groups rather than stages. For most childhood cancers — particularly leukaemia and lymphoma — treatment is not based purely on a TNM stage number as in many adult cancers. Instead, each child is assigned to a risk group based on a combination of factors that predict how likely the cancer is to respond to treatment.

For acute lymphoblastic leukaemia (ALL) — the most common childhood cancer — the risk group is determined by:

• The child's age at diagnosis
• The white blood cell count at the time of diagnosis
• Whether the leukaemia has spread to the brain or spinal fluid
• Specific chromosomal changes in the leukaemia cells — some predict a better response to chemotherapy; others indicate the need for more intensive treatment
• How quickly and completely the leukaemia responds to the first weeks of chemotherapy

Children in a standard or low-risk group receive effective but less intensive chemotherapy — reducing side effects and long-term effects. Those in a high-risk group receive more intensive treatment. This personalised approach is why cure rates for childhood leukaemia have improved so dramatically over the past 40 years. CION's haematology and medical oncology team applies current international risk-stratification guidelines to every childhood leukaemia and lymphoma diagnosis.

What Does Childhood Cancer Treatment Actually Involve? — The ALL Example

For many parents, the most important practical question is: what is ahead of us? Using ALL — the most common childhood cancer — as an example, here is what the treatment journey typically looks like.

Life After Treatment — Understanding Long-Term Effects

For children who are cured of cancer — and the majority are — the focus shifts to a question that is on every parent's mind from the beginning: will the treatment affect my child's long-term health, growth, and development?

The honest answer is that some childhood cancer treatments can have long-term effects — and knowing what to monitor for allows early intervention.

• Growth — some chemotherapy medicines and radiation to the spine or pituitary area can affect growth hormone production; regular measurement and, where needed, growth hormone supplementation manages this
• Heart function — certain chemotherapy medicines can, at high cumulative doses, affect heart muscle function; regular cardiac monitoring (echocardiograms) is recommended for children who received these medicines
• Cognitive development and learning — brain radiation, particularly to young children, can affect concentration, memory, and learning; modern radiation planning minimises this, and educational support helps children reach their potential
• Fertility — some chemotherapy medicines and radiation to the pelvic area can affect future fertility; fertility preservation measures (such as freezing sperm in older boys) can be discussed before treatment begins where appropriate
• Second cancers — a small proportion of childhood cancer survivors have a slightly higher lifetime risk of a second cancer; this is why long-term follow-up care (survivorship clinics) matters

CION's oncology team discusses late effects monitoring with every family during treatment planning. Long-term follow-up after treatment completion includes regular reviews designed to catch any late-emerging effects early.

Childhood Cancer Treatment at CION Cancer Clinics

CION follows NCCN and international paediatric oncology treatment protocols for every cancer subtype. Every child's treatment plan is reviewed and approved by our multidisciplinary tumour board before initiation.

Haematology — Blood Cancers (Leukaemia and Lymphoma)

Leukaemia and lymphoma together account for approximately 50% of all childhood cancers. CION's haematology team manages the full range of childhood blood cancers using current international treatment protocols — risk-stratified chemotherapy regimens, spinal fluid protection, and close monitoring through each treatment phase. Day-care chemotherapy delivery means children can receive treatment close to home, across any of CION's 7 Hyderabad locations, reducing travel burden on families.

Medical Oncology — Chemotherapy for Solid Tumours

For children with solid tumours — neuroblastoma, Wilms tumour, hepatoblastoma, and bone sarcomas — the medical oncology team manages chemotherapy before and after surgery, applying paediatric dosing calculations and monitoring for side effects throughout. The chemotherapy protocols used are aligned with international guidelines (NCCN, COG), adapted for each child's age, weight, and risk group.

Surgical Oncology — Childhood Solid Tumour Surgery

CION's surgical oncology team performs tumour removal for childhood solid tumours — kidney tumours (Wilms tumour), adrenal and abdominal neuroblastoma, liver tumours, and bone sarcomas — following pre-surgical chemotherapy where indicated. For bone sarcomas in the limbs (osteosarcoma, Ewing sarcoma), limb-sparing surgery with expandable metallic implants that grow with the child is the standard approach, avoiding amputation in the vast majority of cases.

Radiation Therapy for Childhood Cancers

When radiation is indicated — for brain tumours, Ewing sarcoma, selected leukaemias, or lymphomas — CION's radiation oncology team delivers treatment using IMRT, with paediatric-specific dose constraints to protect developing organs. Radiation in children requires detailed planning to minimise dose to the brain, spine, growth plates, and reproductive organs. Where possible, chemotherapy is used to reduce the need for radiation or to lower the dose required.

When Bone Marrow Transplant Is Needed

Some children — particularly those with high-risk or relapsed leukaemia — require a bone marrow transplant (stem cell transplant) as part of their treatment. This is a highly specialised procedure available at dedicated transplant centres. CION coordinates referrals to appropriate bone marrow transplant centres for children who require this step, ensuring continuity of care and clear communication between teams.

Every Child's Case Reviewed by a Specialist Team

Childhood cancer management requires haematology, medical oncology, surgical oncology, radiation oncology, and supportive care to work together from the start. At CION, every paediatric cancer case is reviewed by our multidisciplinary tumour board before any treatment plan is finalised:

• Cancer type confirmed and risk group assigned — personalised treatment intensity determined
• Blood cancer protocol selected based on current NCCN and international paediatric oncology guidelines
• Pre-surgical chemotherapy planned for solid tumours (Wilms, neuroblastoma, osteosarcoma, Ewing sarcoma)
• Radiation therapy planned with paediatric dose constraints where needed
• Bone marrow transplant referral coordinated where indicated
• Nutritional support — oncology dietitian involvement to maintain the child's strength throughout treatment
• Pain and symptom management — paediatric-appropriate supportive care throughout
• Psychological support for the child and family — CION's team ensures families are supported at every step
• Long-term follow-up planning for late effects monitoring from the time of diagnosis
• Digital coordination across all 7 Hyderabad locations — families can receive treatment at the nearest centre

Childhood Cancer Treatment Cost in Hyderabad

Treatment costs vary significantly by cancer type, risk group, and duration. Blood cancers (leukaemia) involve long treatment courses; solid tumours involve surgery combined with chemotherapy.

Costs are indicative. A personalised treatment cost estimate is provided after initial oncology consultation at CION.

Financial Support Options

• EMI Facility — flexible instalment-based payment options available for all patients.
• Private Health Insurance — CION works with all major TPAs for cashless hospitalisation.

Paediatric Cancer Care Near You — In Hyderabad & Beyond

CION operates 35+ centres across Telangana and Andhra Pradesh. Find your nearest paediatric cancer specialist or explore care options in your city.

Paediatric Cancer Care in Hyderabad — by Location

Paediatric Cancer Care Beyond Hyderabad

Travelling for treatment? We may have a centre right where you are — across Telangana and Andhra Pradesh.

Not seeing your city? Call 18002028726 — we'll connect you to the nearest CION centre or arrange a teleconsultation.

Get a Free Written Second Opinion from CION's Tumour Board

Our multidisciplinary team reviews your child's imaging, bone marrow reports, and pathology — before any chemotherapy, surgery, or radiation begins.

Frequently Asked Questions

Common questions about paediatric cancer treatment in Hyderabad — answered by CION's oncology team.

Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist or paediatric oncology specialist for guidance specific to your child's medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.